ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 69.10
+2.90 (4.38%)
At close: Dec 5, 2025
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 4.23 billion as of December 5, 2025. Its market cap has increased by 187.92% in one year.
Market Cap
4.23B
Enterprise Value
3.79B
Revenue
36.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
69.10
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 1.38B to 4.23B, an increase of 206.51%. That is a compound annual growth rate of 29.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.23B | 170.45% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.98M | -31.96% |
| Jul 27, 2021 | 1.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Lin BioScience | 32.35B |
| Center Laboratories | 27.88B |